What is the diagnostic approach to interstitial lung disease - when is HRCT sufficient vs surgical lung biopsy needed?

1 Answer

This 60-year-old gentleman presents with progressive exertional dyspnea, chronic dry cough, and HRCT findings of basal-predominant honeycombing with traction bronchiectasis. The first step is to determine whether this represents a UIP pattern and then systematically exclude secondary causes of interstitial lung disease. A detailed history should focus on environmental and occupational exposures, smoking history, medications, radiation exposure, and symptoms suggestive of connective tissue disease. Autoimmune serologies including ANA, RF, anti-CCP, ENA profile, and myositis-specific antibodies should be obtained when clinically indicated. The HRCT findings described are highly suggestive of a definite UIP pattern. In the absence of an identifiable cause, this would strongly favor Idiopathic Pulmonary Fibrosis (IPF). Pulmonary function testing, including DLCO and six-minute walk assessment, should be performed to establish baseline disease severity and monitor progression. When is Lung Biopsy Warranted? Lung biopsy is generally not required when HRCT demonstrates a definite UIP pattern characterized by subpleural and basal predominance, honeycombing, and traction bronchiectasis, particularly in the appropriate clinical setting. Biopsy should be considered when: * HRCT findings are indeterminate. * A probable UIP pattern is present without classic honeycombing. * Alternative diagnoses such as chronic hypersensitivity pneumonitis, NSIP, sarcoidosis, or connective tissue disease-associated ILD remain under consideration. * Multidisciplinary discussion fails to reach a confident diagnosis. Whenever possible, diagnosis should be established through a multidisciplinary discussion involving pulmonology, thoracic radiology, and pathology teams. Likely Diagnosis Based on the clinical presentation and HRCT findings provided, the most likely diagnosis is **Idiopathic Pulmonary Fibrosis (IPF)** with a UIP pattern. In this scenario, biopsy would typically not be necessary, and management should focus on disease staging, antifibrotic therapy, pulmonary rehabilitation, and long-term monitoring. Key Point: A definite UIP pattern on HRCT in the appropriate clinical context is usually sufficient to establish the diagnosis of IPF without surgical lung biopsy.